JPWO2023005928A5 - - Google Patents
Info
- Publication number
- JPWO2023005928A5 JPWO2023005928A5 JP2024504951A JP2024504951A JPWO2023005928A5 JP WO2023005928 A5 JPWO2023005928 A5 JP WO2023005928A5 JP 2024504951 A JP2024504951 A JP 2024504951A JP 2024504951 A JP2024504951 A JP 2024504951A JP WO2023005928 A5 JPWO2023005928 A5 JP WO2023005928A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- mmol
- cancer
- oxa
- azabicyclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110860428.3 | 2021-07-27 | ||
| CN202110860428 | 2021-07-27 | ||
| CN202210779302.8 | 2022-07-01 | ||
| CN202210779302 | 2022-07-01 | ||
| PCT/CN2022/107932 WO2023005928A1 (zh) | 2021-07-27 | 2022-07-26 | 8-氧-3-氮杂二环[3.2.1]辛烷类化合物或其盐及其制备方法和用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024527044A JP2024527044A (ja) | 2024-07-19 |
| JP2024527044A5 JP2024527044A5 (https=) | 2025-07-30 |
| JPWO2023005928A5 true JPWO2023005928A5 (https=) | 2025-07-30 |
Family
ID=85060847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024504951A Pending JP2024527044A (ja) | 2021-07-27 | 2022-07-26 | ８－オキソ－３－アザビシクロ［３．２．１］オクタン系化合物及びその塩、並びにその調製方法及び使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240294550A1 (https=) |
| EP (1) | EP4378943A4 (https=) |
| JP (1) | JP2024527044A (https=) |
| KR (1) | KR20240041354A (https=) |
| CN (2) | CN115677730B (https=) |
| AU (1) | AU2022316931A1 (https=) |
| CA (1) | CA3227713A1 (https=) |
| IL (1) | IL310412A (https=) |
| TW (1) | TW202321256A (https=) |
| WO (1) | WO2023005928A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202602891A (zh) * | 2024-03-28 | 2026-01-16 | 大陸商勵締（杭州）醫藥科技有限公司 | 具有mTOR抑制活性的有機化合物及其用途 |
| TW202545519A (zh) * | 2024-05-15 | 2025-12-01 | 俄羅斯聯邦商拜奧卡德聯合股份公司 | 共濟失調毛細血管擴張症和Ｒａｄ３相關激酶抑制劑 |
| WO2026037494A1 (en) * | 2024-08-14 | 2026-02-19 | Eracal Therapeutics Ltd. | New compounds and their uses |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI700283B (zh) | 2014-08-04 | 2020-08-01 | 德商拜耳製藥公司 | ２-(嗎啉-４-基)-１,７-萘啶 |
| CN109071565B (zh) | 2016-05-24 | 2022-05-10 | 默克专利股份公司 | 三环杂环衍生物 |
| IL281212B2 (en) | 2018-09-07 | 2023-12-01 | Merck Patent Gmbh | 5-Morpholin-4-yl-pyrazolo[4,3-B]pyridine derivatives and their use |
| CR20210281A (es) | 2018-10-30 | 2021-10-25 | Repare Therapeutics Inc | Compuestos, composiciones farmacéuticas y métodos de preparación de compuestos y de uso como inhibidores de la cinasa atr |
| CN111848605B (zh) | 2019-04-30 | 2023-05-02 | 四川科伦博泰生物医药股份有限公司 | 一种取代吡啶并[3,4-b]吡嗪-2(1H)-酮化合物、其制备方法和用途 |
| CN112142744A (zh) * | 2019-06-28 | 2020-12-29 | 上海瑛派药业有限公司 | 取代的稠合杂芳双环化合物作为激酶抑制剂及其应用 |
| MX2022000854A (es) * | 2019-07-22 | 2022-02-10 | Repare Therapeutics Inc | Derivados de 2-morfolinopiridina sustituidos como inhibidores de la cinasa atr. |
| JP2023537055A (ja) * | 2020-08-07 | 2023-08-30 | アンテンジーン・ディスカバリー・リミテッド | Ａｔｒ阻害剤およびその使用 |
-
2022
- 2022-07-26 KR KR1020247006386A patent/KR20240041354A/ko active Pending
- 2022-07-26 IL IL310412A patent/IL310412A/en unknown
- 2022-07-26 CN CN202210884665.8A patent/CN115677730B/zh active Active
- 2022-07-26 JP JP2024504951A patent/JP2024527044A/ja active Pending
- 2022-07-26 CA CA3227713A patent/CA3227713A1/en active Pending
- 2022-07-26 TW TW111127974A patent/TW202321256A/zh unknown
- 2022-07-26 AU AU2022316931A patent/AU2022316931A1/en active Pending
- 2022-07-26 WO PCT/CN2022/107932 patent/WO2023005928A1/zh not_active Ceased
- 2022-07-26 CN CN202280052257.4A patent/CN118043325A/zh active Pending
- 2022-07-26 US US18/292,437 patent/US20240294550A1/en active Pending
- 2022-07-26 EP EP22848533.0A patent/EP4378943A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7644517B2 (ja) | Ｋｒａｓ突然変異型タンパク質阻害剤 | |
| CN112094269B (zh) | 一类饱和六元环并杂环类化合物、制备方法和用途 | |
| JP7248256B2 (ja) | Ｊａｋキナーゼ阻害剤及びその調製方法、並びにその医薬分野での使用 | |
| JP6587116B2 (ja) | キナゾリン化合物 | |
| JP2025523624A (ja) | がんの治療のための方法 | |
| US20240270753A1 (en) | Heterocyclic compound for inhibiting shp2 activity, preparation method therefor and use thereof | |
| KR101829940B1 (ko) | 프탈라지논 케톤 유도체, 이의 제조방법, 및 이의 약학적 용도 | |
| KR20250070059A (ko) | 신규한 테트라헤테로사이클 화합물 | |
| CN117917416A (zh) | Kras g12d降解剂及其制备方法和应用 | |
| JP2023518609A (ja) | 新規アミノピリミジン系ｅｇｆｒ阻害剤 | |
| PT2989106T (pt) | Compostos heterocíclicos fundidos como inibidores da proteína quinase | |
| EP3556761B1 (en) | Pyrrolo-aromatic heterocyclic compound, preparation method therefor, and medical use thereof | |
| JP6785876B2 (ja) | ピリド［３，４−ｄ］ピリミジン誘導体及びその薬学的に許容される塩 | |
| TW202237597A (zh) | 新型egfr降解劑 | |
| JP2024527044A (ja) | ８－オキソ－３－アザビシクロ［３．２．１］オクタン系化合物及びその塩、並びにその調製方法及び使用 | |
| WO2017071516A1 (zh) | 一种蛋白激酶抑制剂及其制备方法和医药用途 | |
| US20240383911A1 (en) | Azaindazole macrocycle compounds and uses thereof | |
| TW202110848A (zh) | 取代的稠合雙環類衍生物、其製備方法及其在醫藥上的應用 | |
| WO2022253309A1 (zh) | 取代的杂环化合物及其应用 | |
| CN120535527A (zh) | 一类含氮稠环类化合物、制备方法和用途 | |
| JP7833477B2 (ja) | 血管拡張性失調症変異（ａｔｍ）キナーゼの選択的モジュレーターおよびその使用 | |
| JPWO2023005928A5 (https=) | ||
| CN117586256A (zh) | 取代的杂环化合物 | |
| EA050883B1 (ru) | 8-окса-3-азабицикло[3.2.1]октановые соединения или их соли, способ их получения и применение | |
| CN116444497B (zh) | 一类哒嗪酮类化合物、制备及其应用 |